DESTINY-PanTumor02
Phase II study evaluating the role of HER2-directed ADC Trastuzumab deruxtecan (T-DxD)
Endometrial Cancer
Minimally Invasive Surgery in Endometrial Cancer
A systematic review and a meta-analysis supporting the safety of MIS in high-risk endometrial cancer
ASTRO Endometrial Cancer Guidelines 2023
Updated ASTRO guidelines and management of endometrial cancer with radiation therapy